|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/715 |
| (11) | Patento numeris | 2906227 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13844631.5 |
| Europos patento paraiškos padavimo data | 2013-10-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/064322 |
| Data | 2013-10-10 |
| (87) | Numeris | WO 2014/059135 |
| Data | 2014-04-17 |
| (30) | Numeris | Data | Šalis |
| 201261711929 P | 2012-10-10 | US |
| (72) |
TRABER, Peter, G., US
ZOMER, Eliezer, US
|
| (73) |
Galectin Therapeutics Inc.,
4960 Peachtree Industrial Blvd. Suite 240, Norcross, GA 30071,
US
|
| (54) | GALACTOSE-PRONGED CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS |
| GALACTOSE-PRONGED CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS |